MSQ CEO Webinar Series

Connecting Global Biopharma Leaders Through Insights and Conversation

 

Table of Contents ↓

BAW Series↓

Successful Fundraising in Today’s Market

Unveiling What's New, Expert Insights and Viewpoints in Targeted Protein Degradation (TPD) PART 2

Unveiling What's New, Expert Insights and Viewpoints in Targeted Protein Degradation (TPD) PART 1

Global ADC Drug Development & China Opportunities

CASE STUDY: ImaginAB & DC Pharma Successful Case Study and Knowledge Sharing

CASE STUDY: BioInvent International AB & CASI Pharmaceuticals, Inc. Successful Case Study

Key Considerations and Strategies Accelerating Rare Disease Drug Development & Global Capital Market Forecast

How does China joining the ICH Impact the Dynamics of Global Clinical Trial Design? & A Leap from Regional to Global Deals: China Biopharma’s Licensing Strategy Revolution

China for Global: Out-Licensing Opportunities, Challenges, and Perspectives & Cross-Border Collaboration Opportunities: Unmet Medical Needs and Emerging Technologies in China

Subverting the traditional treatment concept and breaking the situation of tumor immunotherapy

Global Biopharma Collaboration Opportunities and Challenges in 2021

MSQ WEBINAR Series↓

Advancements in Autism Treatment: Curemark's Pioneering Approaches

Innovations in CNS Therapies: NeuShen’s Unique Discovery to Development Approach

BioVersys: Impactful Solutions for Antimicrobial Resistance (AMR)

Geoffrey Banks: Learn How to Increase Pharmaceutical Asset Valuations Using Industry-standard, Strategic Clinical Pharmacology Techniques

Ocuphire Pharma: A Clear Focus on Retinal and Refractive Eye Disorders

Hamlet Biopharma: Innovations in Cancer and Infection Treatment

TheiaLife Sciences: A Disruptive Clinical Stage Novel Ophthalmology Asset

Oncoinvent: ONCOINVENT & RADSPHERIN® - A Novel Alpha-Emitting and Non-Systemic Radiopharmaceutical Concept in Clinical Development

Elucida Oncology: Beyond Anti-Body Drug Conjugates – A New Enhanced Approach

CytomX Therapeutics: Localized Biologic Modalities for Cancer Treatment

AUTOTAC Bio: Innovative Drug Platforms: Targeted Protein Degradation Using Autophagy

BiOneCure Therapeutics: Developing Innovative Anti-Drug Conjugates (ADCs) for Solid Tumor Treatment

Chimeric Therapeutics: Bringing the Promise of Cell Therapy to Life for More Patients

ImaginAb: Developing Next-Gen Imaging Agents & Radiopharmaceutical Therapy Products

Anveon: Transforming Powerful Cytokines into Life-Saving Treatment

Apollomics: Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers

Anavex Life Sciences: Treating Neurodegenerative/Developmental Disorders to Reverse CNS Conditions

ONL Therapeutics: Developing First-In-Class Therapeutics to Protect the Vision of Patients with Retinal Disease

Aruna Biosciences: Proprietary Neural Exosome Platform for Neurological Diseases

FDA/EMA Approved Drugs Entering China Market without NMPA’s Approval

Jones Day: China's "Hatch-Waxman Act" - IP Strategy for Innovative Drugs Entering China Market

From Chasing My Cure to Chasing COVID’s Cure

I-Mab Biopharma: Bringing In The Catalyst For Positive Change

Open Orphan: Lining Up The Role In Coronavirus Fight

Harbour BioMed: Opportunities Among Uncertainties

TYME: Evolving Science Development of Cancer Metabolism-Based Therapies

Phagelux: Fighting Virus Pandemics: The Now and The Future - Expert’s Perception of Challenges and Opportunities with Dr. Shawn Shi and Mr. Mark Engel

Distributed Bio: How to Execute Global Licensing Deals in Biotech Industry

Distributed Bio: A Talk with Jacob Glanville: Computational Immunology vs COVID-19

Harnessing the Power of NK Cells to Defeat Cancer

Median Technologies: Fighting Virus Pandemics: The Now and The Future - Expert’s Perception of Challenges & Opportunities with Echo Hindle-Yang, Fredrik Brag & Dr. Shawn Shi

Aqualung Therapeutics: Fighting Virus Pandemics: The Now and The Future - Expert’s Perception of Challenges & Opportunities with Echo Hindle-Yang, Stan Miele & Dr. Shawn Shi

Share Capital & Chance Pharmaceuticals: COVID-19 & Impact on Global Clinical Trial Cooperation

Dyadic International: Fighting Virus Pandemics: The Now and The Future - Expert’s Perception of Challenges & Opportunities with Echo Hindle-Yang, Ping Wang Rawson & Dr. Shawn Shi

Zhong Lun Law Firm: The importance of IP protection & Case studies in cross-border biotech investments

Leidos: Fighting Virus Pandemics: The Now and The Future - Expert’s Perception of Challenges & Opportunities with Dr. John Ma, Dr. Gabriel Gutierrez, Dr. Jim Pannucci & Dr. Shawn Shi

Antengene & CanSino Biologics: COVID-19 & Impact on Cross-border Healthcare Cooperation with Echo Hindle-Yang, Dr. Jay Mei, Dr. Dongxu Qiu & Dr. Shawn Shi

Atriva Therapeutics: Fighting Virus Pandemics: The Now and The Future - Expert’s Perception of Challenges & Opportunities with Echo Hindle-Yang & Dr. Rainer Lichtenberger

Apollomics & LYFE Capital: COVID-19 & Impact on Cross-border Healthcare Cooperation with Echo Hindle-Yang, Dr. Guo-Liang Yu, Dr. Shawn Shi & James Zhao